Stockscreener 앱 받기
3.303
28.35%
-1.307
시간 외 거래:
3.70
0.397
+12.02%
전일 마감가:
$4.61
열려 있는:
$4
하루 거래량:
131.43K
Relative Volume:
0.02
시가총액:
$3.65M
수익:
-
순이익/손실:
$-15.42M
주가수익비율:
-1.7951
EPS:
-1.84
순현금흐름:
$-13.41M
1주 성능:
-49.18%
1개월 성능:
-57.10%
6개월 성능:
+306.77%
1년 성능:
+118.74%
1일 변동 폭
$3.205
$4.8994
1주일 범위
$3.205
$6.65
52주 변동 폭
$0.2701
$13.40
Indaptus Therapeutics Inc Stock (INDP) Company Profile
명칭
Indaptus Therapeutics Inc
전화
(646) 427-2727
주소
3 COLUMBUS CIRCLE, NEW YORK
INDP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INDP
Indaptus Therapeutics Inc
|
3.303 | 5.10M | 0 | -15.42M | -13.41M | -1.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Indaptus Therapeutics Inc 주식(INDP)의 최신 뉴스
Order flow analysis tools used on Indaptus Therapeutics Inc.July 2025 Opening Moves & Intraday High Probability Alerts - Newser
Will Indaptus Therapeutics Inc. stock go up soonTrade Ideas & Long Hold Capital Preservation Tips - Newser
Can Indaptus Therapeutics Inc. be recession proofEarnings Trend Report & Precise Swing Trade Alerts - خودرو بانک
How to monitor Indaptus Therapeutics Inc. with trend dashboardsEarnings Recap Report & Daily Profit Maximizing Tips - Newser
Can Indaptus Therapeutics Inc. keep up with sector leadersJuly 2025 Highlights & Target Return Focused Picks - خودرو بانک
Indaptus Therapeutics Inc. stock momentum explainedWeekly Stock Recap & Low Risk Entry Point Guides - Newser
Does Indaptus Therapeutics Inc. have a sustainable dividendMarket Rally & Long-Term Growth Plans - خودرو بانک
Published on: 2025-09-05 13:40:19 - Newser
Aug Movers: Is Indaptus Therapeutics Inc. stock influenced by commodity pricesGold Moves & Consistent Profit Trading Strategies - خودرو بانک
Indaptus reports partial response in cancer patient with Decoy20 By Investing.com - Investing.com Australia
Indaptus Therapeutics stock falls after mixed clinical trial updates By Investing.com - Investing.com UK
Indaptus Therapeutics stock falls after mixed clinical trial updates - Investing.com
How to use Fibonacci retracement on Indaptus Therapeutics Inc.2025 Market Trends & Expert Curated Trade Ideas - Newser
Evaluating Indaptus Therapeutics Inc. with trendline analysisWeekly Trading Summary & Weekly Stock Breakout Alerts - Newser
Is Indaptus Therapeutics Inc. forming a bottoming baseQuarterly Performance Summary & Weekly High Return Stock Opportunities - Newser
Century Therapeutics shares rise 4.38% premarket after Indaptus Therapeutics reported positive clinical trial results. - AInvest
How sentiment analysis helps forecast Indaptus Therapeutics Inc.Weekly Gains Report & Fast Exit Strategy with Risk Control - Newser
Indaptus Therapeutics Inc. stock trend outlook and recovery pathEarnings Miss & High Conviction Investment Ideas - Newser
Signal strength of Indaptus Therapeutics Inc. stock in tech scannersPortfolio Performance Report & Low Drawdown Momentum Trade Ideas - Newser
Indaptus Therapeutics provides clinical update - MarketScreener
Indaptus reports partial response in cancer patient with Decoy20 - Investing.com
Indaptus Therapeutics Provides Clinical Update - GlobeNewswire
Cancer Drug Shrinks Liver Metastases: Indaptus's Decoy20 Shows Promise in Urothelial Cancer Patient Study - Stock Titan
Will Indaptus Therapeutics Inc. stock recover after recent dropProduct Launch & Technical Buy Zone Confirmation - Newser
Applying big data sentiment scoring on Indaptus Therapeutics Inc.2025 Market Trends & Verified Entry Point Signals - Newser
Is Indaptus Therapeutics Inc. meeting your algorithmic filter criteriaMarket Performance Recap & High Accuracy Swing Entry Alerts - Newser
What are Indaptus Therapeutics Inc.’s earnings expectationsJuly 2025 Action & Long-Term Investment Growth Plans - خودرو بانک
News impact scoring models applied to Indaptus Therapeutics Inc.Market Weekly Review & Fast Entry High Yield Stock Tips - Newser
Published on: 2025-09-03 05:54:24 - Newser
What MACD signals say about Indaptus Therapeutics Inc.July 2025 News Drivers & High Accuracy Investment Signals - Newser
Can Indaptus Therapeutics Inc. sustain its profitabilityJobs Report & Weekly Setup with High ROI Potential - خودرو بانک
Real time alert setup for Indaptus Therapeutics Inc. performanceJuly 2025 Sentiment & Technical Confirmation Alerts - Newser
Indaptus Therapeutics to Present at the H.C. Wainwright 27ᵗʰ Annual Global Investment Conference - GlobeNewswire
Biotech Indaptus Therapeutics Joins Major Healthcare Conference: CEO to Present Latest Developments - Stock Titan
Comparing Indaptus Therapeutics Inc. in custom built stock radarsEarnings Summary Report & Free Community Consensus Stock Picks - Newser
Short interest data insights for Indaptus Therapeutics Inc.Sell Signal & Real-Time Buy Zone Alerts - Newser
Indaptus Therapeutics Inc (INDP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):